Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Pediatrics, Division of Pediatric Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Eur J Pediatr. 2019 Jan;178(1):97-103. doi: 10.1007/s00431-018-3268-x. Epub 2018 Oct 17.
Pulse oximetry (PO) screening is used to screen newborns for critical congenital heart defects (CCHD). Analyses performed in hospital settings suggest that PO screening is cost-effective. We assessed the costs and cost-effectiveness of PO screening in the Dutch perinatal care setting, with home births and early postnatal discharge, compared to a situation without PO screening. Data from a prospective accuracy study with 23,959 infants in the Netherlands were combined with a time and motion study and supplemented data. Costs and effects of the situations with and without PO screening were compared for a cohort of 100,000 newborns. Mean screening time per newborn was 4.9 min per measurement and 3.8 min for informing parents. The additional costs of screening were in total €14.71 per screened newborn (€11.00 personnel, €3.71 equipment costs). Total additional costs of screening and referral were €1,670,000 per 100,000 infants. This resulted in an incremental cost-effectiveness ratio of €139,000 per additional newborn with CCHD detected with PO, when compared to a situation without PO screening. A willingness-to-pay threshold of €20,000 per gained QALY for screening in the Netherlands makes the screening likely to be cost-effective.Conclusion: PO screening in the Dutch care setting is likely to be cost-effective. What is Known: • Pulse oximetry is increasingly implemented as a screening tool for critical congenital heart defects in newborns. • Previous studies suggest that the screening in cost-effective and in the USA a reduction in infant mortality from critical congenital heart defects was demonstrated. What is New: • This is the first cost-effectiveness analysis for pulse oximetry screening in a setting with screening after home births, with screening at two moments. • Costs of pulse oximetry screening in a setting with hospital and homebirth deliveries were €14.71 and is likely to be cost-effective accordint to Dutch standards.
脉搏血氧饱和度(PO)筛查用于筛查新生儿的严重先天性心脏缺陷(CCHD)。在医院环境中进行的分析表明,PO 筛查具有成本效益。我们评估了在荷兰围产期护理环境中进行 PO 筛查的成本和成本效益,包括家庭分娩和早期产后出院,与不进行 PO 筛查的情况相比。对荷兰的一项前瞻性准确性研究中的 23959 名婴儿的数据进行了分析,该研究结合了时间和动作研究以及补充数据。对 100000 名新生儿的队列比较了有和没有 PO 筛查的情况的成本和效果。每个新生儿的平均筛查时间为每次测量 4.9 分钟,告知父母 3.8 分钟。筛查的额外成本总计为每个筛查新生儿 14.71 欧元(11.00 欧元人员,3.71 欧元设备成本)。筛查和转介的总额外成本为每 100000 名婴儿 167 万欧元。这导致 PO 检测到 CCHD 的新生儿每增加 1 例,增量成本效益比为 139000 欧元,而不进行 PO 筛查的情况下则为 139000 欧元。荷兰对筛查的意愿支付阈值为每获得一个 QALY 增加 20000 欧元,这使得筛查具有成本效益。结论:荷兰护理环境中的 PO 筛查可能具有成本效益。已知:•脉搏血氧饱和度作为新生儿严重先天性心脏缺陷的筛查工具越来越多地得到应用。•先前的研究表明,该筛查具有成本效益,在美国,致命性先天性心脏缺陷的婴儿死亡率有所降低。新内容:•这是首次在家庭分娩后进行两次筛查的环境中进行脉搏血氧饱和度筛查的成本效益分析。•在有医院和家庭分娩的环境中进行脉搏血氧饱和度筛查的成本为 14.71 欧元,根据荷兰标准,该筛查可能具有成本效益。